Clinical Trials
MarrowStim™ P.A.D. Kit
For Critical Limb Ischemia (CLI) in subjects with severe Peripheral Arterial Disease (PAD)
An FDA-Approved Research Trial
The MarrowStim™ P.A.D. Kit is an Investigational Device that is not approved by the Food and Drug Administration (FDA). The purpose of this research is to study the safety and effectiveness of a new investigational treatment for patients suffering from severe peripheral arterial disease (PAD) utilizing their own concentrated bone marrow aspirate. The bone marrow aspirate is obtained from the patient's hip bones and concentrated with the MarrowStim™ P.A.D. Kit. Concentrated bone marrow aspirate contains mononuclear cells that may have the potential to treat diseased vascular structures.
Study participants will be randomized to receive either MarrowStim™ treatment or placebo. Three out of every four participants (75%) will receive MarrowStim™ treatment and one out of every four (25%) will receive placebo. MarrowStim™ treatment involves the administration of concentrated bone marrow aspirate to the patient's affected limb.
 |
 |
| MarrowStim™ Device | MarrowStim™ Treatment |
Patients meeting the pre-defined inclusion/exclusion criteria are eligible for this clinical trial.
For more information, call toll free 877-788-3972 or contact one of the study locations listed below.
ALABAMAThe University of Alabama at Birmingham
Birmingham, Alabama
Contact: Juli Burks
Phone: 205-934-7279
Email: Juli.Burks@ccc.uab.edu
ARKANSAS
Central Arkansas Veterans Healthcare System
Little Rock, Arkansas
Contact: Sandra Brock
Phone: 501-257-6906
Email: brocksandraj@uams.edu
CALIFORNIA
University of California - Davis Medical Center
Sacramento, California
Contact: Christy Pifer
Phone: 916-734-4156
FLORIDA
University of Miami
Miami, Florida
Contact: Lynne Sparling
Telephone: 305-243-7298
Email: lsparlin@med.miami.edu
IOWA
University of Iowa Hospitals and Clinics
Iowa City, Iowa
Contact: Anas Eid, MD
Telephone: 319-3561304
Email: anas-eid@uiowa.edu
KENTUCKY
University of Louisville
Louisville, Kentucky
Contact: Jeanine L. Fell
Telephone: 502-852-5895
Email: jlfell01@louisville.edu
MICHIGAN
Spectrum Health
Grand Rapids, Michigan
Contact: Jeanine Holen
Telephone: 616-391-5067
Email: jeanine.holen@spectrumhealth.org
NEW YORK
New York Presbyterian Hospital – Weill Cornell Medical College
New York, New York
Contact: Ruchita Mehta
Telephone: 212-746-5949
Email: rum2006@med.cornell.edu
OHIO
The Cleveland Clinic
Cleveland, Ohio
Contact: Jennifer Seaber
Phone: 216-445-8063
Email: seaberj@ccf.org
TEXAS
Austin Heart Hospital
Austin, Texas
Contact: Paige Musick
Phone: 512-421-3896
Email: pmusick@austinheart.com
Dallas Veterans Affairs Medical Center
Dallas, Texas
Contact: Eric Rosero, MD
Telephone: 214-857-0336
Email: eric.rosero@utsouthwestern.edu
University of North Texas Health Science Center at Fort Worth
Fort Worth, Texas
Contact: Bonnie Wicklund
Telephone: 817-735-0304
Email: Bonnie.Wicklund@unthsc.edu
WASHINGTON
Providence Sacred Heart Medical Center
Spokane, Washington
Contact: Claudia Flores
Telephone: 509-474-4306
Email: claudia.flores@providence.org
Study location information will be added to this section as it becomes available.
Study Participation
If you think you may qualify to participate in this study, please refer to the website link below to obtain further information about participation.
PAD Study Information on Clinical Trial Spotlight
Additional Information
For additional information on this study, please refer to the website link below from ClinicalTrials.gov: